Limit this search to....

The Pharmagellan Guide to Biotech Forecasting and Valuation
Contributor(s): David, Frank S. (Author), Robey, Seth (Author), Matthews, Andrew (Author)
ISBN: 099840750X     ISBN-13: 9780998407500
Publisher: Pharmagellan, LLC
OUR PRICE:   $94.05  
Product Type: Paperback
Published: January 2017
Qty:
Additional Information
BISAC Categories:
- Business & Economics | Forecasting
- Business & Economics | Corporate Finance - Valuation
- Business & Economics | Industries - Pharmaceutical & Biotechnology
Physical Information: 0.32" H x 6" W x 9" (0.47 lbs) 138 pages
 
Descriptions, Reviews, Etc.
Publisher Description:

If you're a biotech executive, investor, deal maker, entrepreneur, or adviser--or aspire to be one--then you need to know how to build and analyze forecasts and valuation models of R&D-stage drugs.

THE PHARMAGELLAN GUIDE TO BIOTECH FORECASTING AND VALUATION is a comprehensive, thoroughly referenced handbook to creating and interpreting financial models for early-stage biopharma assets and companies.


- Vetted benchmarks for key drivers of income, expenses, and valuation.
- Proprietary analyses by Pharmagellan's experienced consulting team.
- More than 150 current references from peer-reviewed research, industry white papers, and SEC filings.

Whether you're making investment decisions, pitching to potential partners or funders, or assessing your own R&D program, this is the one-stop guide you need by your side.